These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31173466)

  • 61. The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway.
    Tajan M; Paccoud R; Branka S; Edouard T; Yart A
    Endocr Rev; 2018 Oct; 39(5):676-700. PubMed ID: 29924299
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways.
    Takenouchi T; Sakamoto Y; Miwa T; Torii C; Kosaki R; Kishi K; Takahashi T; Kosaki K
    Am J Med Genet A; 2014 Nov; 164A(11):2869-72. PubMed ID: 25123707
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Generation of a genetically-modified induced pluripotent stem cell line harboring a Noonan syndrome-associated gene variant MRAS p.G23V.
    Busley AV; Cyganek L
    Stem Cell Res; 2023 Jun; 69():103108. PubMed ID: 37141804
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature.
    Addissie YA; Kotecha U; Hart RA; Martinez AF; Kruszka P; Muenke M
    Am J Med Genet A; 2015 Nov; 167A(11):2657-63. PubMed ID: 26249544
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies.
    Komatsuzaki S; Aoki Y; Niihori T; Okamoto N; Hennekam RC; Hopman S; Ohashi H; Mizuno S; Watanabe Y; Kamasaki H; Kondo I; Moriyama N; Kurosawa K; Kawame H; Okuyama R; Imaizumi M; Rikiishi T; Tsuchiya S; Kure S; Matsubara Y
    J Hum Genet; 2010 Dec; 55(12):801-9. PubMed ID: 20882035
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Distal phalangeal creases--a distinctive dysmorphic feature in disorders of the RAS signalling pathway?
    Ørstavik KH; Tangeraas T; Molven A; Prescott TE
    Eur J Med Genet; 2007; 50(2):155-8. PubMed ID: 17324647
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
    Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MRAS: A Close but Understudied Member of the RAS Family.
    Young LC; Rodriguez-Viciana P
    Cold Spring Harb Perspect Med; 2018 Dec; 8(12):. PubMed ID: 29311130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Noonan syndrome-like phenotype in a patient with heterozygous ERF truncating variant.
    Yamada M; Funato M; Kondo G; Suzuki H; Uehara T; Takenouchi T; Sakamoto Y; Kosaki K
    Congenit Anom (Kyoto); 2021 Nov; 61(6):226-230. PubMed ID: 34184330
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Copy number variants including RAS pathway genes-How much RASopathy is in the phenotype?
    Lissewski C; Kant SG; Stark Z; Schanze I; Zenker M
    Am J Med Genet A; 2015 Nov; 167A(11):2685-90. PubMed ID: 25974318
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome.
    Myers A; Bernstein JA; Brennan ML; Curry C; Esplin ED; Fisher J; Homeyer M; Manning MA; Muller EA; Niemi AK; Seaver LH; Hintz SR; Hudgins L
    Am J Med Genet A; 2014 Nov; 164A(11):2814-21. PubMed ID: 25250515
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Childhood Rhabdomyosarcoma in Association With a RASopathy Clinical Phenotype and Mosaic Germline SOS1 Duplication.
    Salem B; Hofherr S; Turner J; Doros L; Smpokou P
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e278-e282. PubMed ID: 27258033
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.
    Yaoita M; Niihori T; Mizuno S; Okamoto N; Hayashi S; Watanabe A; Yokozawa M; Suzumura H; Nakahara A; Nakano Y; Hokosaki T; Ohmori A; Sawada H; Migita O; Mima A; Lapunzina P; Santos-Simarro F; García-Miñaúr S; Ogata T; Kawame H; Kurosawa K; Ohashi H; Inoue S; Matsubara Y; Kure S; Aoki Y
    Hum Genet; 2016 Feb; 135(2):209-22. PubMed ID: 26714497
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis.
    Takahara S; Inoue SI; Miyagawa-Tomita S; Matsuura K; Nakashima Y; Niihori T; Matsubara Y; Saiki Y; Aoki Y
    EBioMedicine; 2019 Apr; 42():43-53. PubMed ID: 30898653
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Next-generation sequencing identifies rare variants associated with Noonan syndrome.
    Chen PC; Yin J; Yu HW; Yuan T; Fernandez M; Yung CK; Trinh QM; Peltekova VD; Reid JG; Tworog-Dube E; Morgan MB; Muzny DM; Stein L; McPherson JD; Roberts AE; Gibbs RA; Neel BG; Kucherlapati R
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11473-8. PubMed ID: 25049390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations.
    Kratz CP; Zampino G; Kriek M; Kant SG; Leoni C; Pantaleoni F; Oudesluys-Murphy AM; Di Rocco C; Kloska SP; Tartaglia M; Zenker M
    Am J Med Genet A; 2009 May; 149A(5):1036-40. PubMed ID: 19396835
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic landscape of RASopathies in Chinese: Three decades' experience in Hong Kong.
    Yu KPT; Luk HM; Leung GKC; Mak CCY; Cheng SSW; Hau EWL; Chan DKH; Lam STS; Tong TMF; Chung BHY; Lo IFM
    Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):208-217. PubMed ID: 30896080
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Two cases of RIT1 associated Noonan syndrome: Further delineation of the clinical phenotype and review of the literature.
    Milosavljević D; Overwater E; Tamminga S; de Boer K; Elting MW; van Hoorn ME; Rinne T; Houweling AC
    Am J Med Genet A; 2016 Jul; 170(7):1874-80. PubMed ID: 27109146
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis.
    Dentici ML; Niceta M; Lepri FR; Mancini C; Priolo M; Bonnard AA; Cappelletti C; Leoni C; Ciolfi A; Pizzi S; Cordeddu V; Rossi C; Ferilli M; Mucciolo M; Colona VL; Fauth C; Bellini M; Biasucci G; Sinibaldi L; Briuglia S; Gazzin A; Carli D; Memo L; Trevisson E; Schiavariello C; Luca M; Novelli A; Michot C; Sweertvaegher A; Germanaud D; Scarano E; De Luca A; Zampino G; Zenker M; Mussa A; Dallapiccola B; Cavé H; Digilio MC; Tartaglia M
    Eur J Hum Genet; 2024 Aug; 32(8):954-963. PubMed ID: 38824261
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neurofibromatosis-Noonan Syndrome: A Possible Paradigm of the Combination of Genetic and Epigenetic Factors.
    Yapijakis C; Pachis N; Voumvourakis C
    Adv Exp Med Biol; 2017; 987():151-159. PubMed ID: 28971455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.